Premium
Exubera: first inhaled insulin for the management of diabetes
Author(s) -
Barnett Anthony
Publication year - 2007
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.39
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , insulin , interface (matter) , diabetes management , intensive care medicine , endocrinology , engineering , pulmonary surfactant , gibbs isotherm , chemical engineering
Exubera is a dry‐powder inhaled formulation of insulin that has now gained licence approval in the UK for use in patients with both type 1 and type 2 diabetes. Here, Professor Barnett discusses the properties of this novel therapeutic option and its potential role in the current and future management of diabetes. Copyright © 2007 Wiley Interface Ltd